Welcome to the TAFINLAR + MEKINIST Patient Site

Please select a condition

Advanced and Adjuvant BRAF+ Melanoma

TAFINLAR® (dabrafenib) capsules + MEKINIST® (trametinib) tablets are prescription medicines that can be used in combination to treat people with a type of skin cancer called melanoma that has spread to other parts of the body (metastatic) or cannot be removed by surgery (unresectable), and that has a certain type of abnormal "BRAF" (V600E or V600K mutation-positive) gene. TAFINLAR and MEKINIST are prescription medicines that can be used in combination to help prevent melanoma that has a certain type of abnormal "BRAF" gene from coming back after the cancer has been removed by surgery.

BRAF V600E Mutation-Positive Metastatic Non-Small Cell Lung Cancer

TAFINLAR and MEKINIST are prescription medicines that can be used in combination to treat a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other parts of the body (metastatic NSCLC), and that has a certain type of abnormal “BRAF V600E” gene.